CATALOGO DEI PRODOTTI DELLA RICERCA

BELLUOMINI, Lorenzo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.241
EU - Europa 3.537
AS - Asia 2.879
SA - Sud America 412
Continente sconosciuto - Info sul continente non disponibili 137
AF - Africa 131
OC - Oceania 20
Totale 11.357
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.060
RU - Federazione Russa 1.742
SG - Singapore 1.276
IT - Italia 638
CN - Cina 472
BR - Brasile 319
HK - Hong Kong 313
VN - Vietnam 278
DE - Germania 266
FI - Finlandia 152
GB - Regno Unito 144
FR - Francia 127
CA - Canada 109
IN - India 95
SE - Svezia 95
BD - Bangladesh 92
KR - Corea 89
IE - Irlanda 81
PL - Polonia 72
NL - Olanda 66
JP - Giappone 46
ID - Indonesia 43
ES - Italia 33
TR - Turchia 32
AR - Argentina 30
MX - Messico 28
TG - Togo 27
BJ - Benin 25
AT - Austria 21
CZ - Repubblica Ceca 20
NG - Nigeria 20
ZA - Sudafrica 18
AU - Australia 16
CO - Colombia 16
EC - Ecuador 15
PK - Pakistan 14
UA - Ucraina 14
VE - Venezuela 14
IQ - Iraq 13
MY - Malesia 13
JO - Giordania 11
MA - Marocco 11
IR - Iran 10
PH - Filippine 10
BE - Belgio 9
JM - Giamaica 9
AE - Emirati Arabi Uniti 8
CH - Svizzera 8
CR - Costa Rica 8
EG - Egitto 7
LT - Lituania 7
SA - Arabia Saudita 7
TW - Taiwan 7
UZ - Uzbekistan 7
AZ - Azerbaigian 6
CL - Cile 6
DK - Danimarca 6
KZ - Kazakistan 6
HN - Honduras 5
KE - Kenya 5
PT - Portogallo 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
AM - Armenia 4
AO - Angola 4
CY - Cipro 4
DZ - Algeria 4
IL - Israele 4
RS - Serbia 4
SV - El Salvador 4
TN - Tunisia 4
BO - Bolivia 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PY - Paraguay 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
AL - Albania 2
BG - Bulgaria 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GR - Grecia 2
GT - Guatemala 2
HR - Croazia 2
KH - Cambogia 2
LB - Libano 2
LV - Lettonia 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
RO - Romania 2
SN - Senegal 2
SY - Repubblica araba siriana 2
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BS - Bahamas 1
GD - Grenada 1
Totale 11.205
Salva come PNG Salva come JPEG
Città #
Singapore 682
Ashburn 652
Moscow 617
Dallas 572
San Jose 562
Hong Kong 299
Council Bluffs 207
Verona 175
Chandler 155
Munich 154
Los Angeles 123
The Dalles 122
Beijing 96
New York 93
Ho Chi Minh City 87
Helsinki 84
Dublin 77
Milan 69
Hanoi 57
London 51
Santa Clara 49
São Paulo 44
Buffalo 41
Meda 38
Tokyo 38
Chicago 36
Redondo Beach 36
Rome 33
Warsaw 32
McKinney 31
Toronto 29
Lappeenranta 28
Montreal 28
Orem 28
Turku 28
Houston 27
Lomé 27
Cotonou 25
Phoenix 25
Jakarta 24
Amsterdam 23
Frankfurt am Main 23
Nuremberg 23
Brooklyn 22
Denver 22
Atlanta 21
Redmond 21
Boardman 20
Lawrence 20
Naples 20
Princeton 20
Columbus 19
Da Nang 19
Seattle 19
Abuja 18
Chennai 18
Sindelfingen 18
Seoul 17
Washington 17
Bologna 15
Haiphong 15
Mumbai 15
Stockholm 15
Johannesburg 14
San Francisco 14
Boston 13
Barnet 12
Belo Horizonte 12
Cleveland 12
New Delhi 12
Shanghai 12
Wilmington 12
Charlotte 11
Istanbul 11
Turin 11
Amman 10
Annandale 10
Brno 10
Falkenstein 10
Jacksonville 10
Philadelphia 10
Porto Alegre 10
Tianjin 10
Vienna 10
Biên Hòa 9
Brussels 9
Hyderabad 9
Paris 9
Piscataway 9
Rio de Janeiro 9
Sydney 9
Vicenza 9
Bursa 8
Chapel Hill 8
City of London 8
Guangzhou 8
Kyiv 8
Manchester 8
Ottawa 8
Poplar 8
Totale 6.393
Salva come PNG Salva come JPEG
Nome #
Exploring the Complex Interplay between Myeloid-Derived Suppressor Cells (MDSCs), Interleukins, and Immune Checkpoint Inhibitors (ICIs) in Non-Small Cell Lung Cancer (NSCLC) 323
Immune checkpoint blockade therapy mitigates systemic inflammation and affects cellular FLIP-expressing monocytic myeloid-derived suppressor cells in non-progressor non-small cell lung cancer patients 323
Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic 204
A multimodal approach to cancer-related cachexia: from theory to practice 203
A Feasibility Study Investigating an Exercise Program in Metastatic Cancer Based on the Patient-Preferred Delivery Mode 194
A cross-sectional study evaluating the exercise discussion with oncologist during cancer consultation: the CONNECT study 189
Exercise prehabilitation in lung cancer: Getting stronger to recover faster 185
Abscopal effect and resistance reversion in nivolumab-treated non-small-cell lung cancer undergoing palliative radiotherapy: a case report 181
ARID1A mutational status in non-small cell lung cancer: from molecular pathology to clinical implications with a focus on the relationships with EGFR 176
Integrating supportive care into the multidisciplinary management of lung cancer: we can't wait any longer 176
A narrative review on tumor microenvironment in oligometastatic and oligoprogressive non-small cell lung cancer: a lot remains to be done 174
Anticipating EGFR Targeting in Early Stages of Lung Cancer: Leave No Stone Unturned 173
How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center 172
A qualitative study exploring the experiences and perspectives of patients with cancer attending a 12-week exercise program 171
Characterizing the immune tumor microenvironment in ALK fusion-positive lung cancer: state-of-the-art and therapeutical implications 167
A cross-sectional study exploring the perception of exercise oncology in the Italian population 166
Antibody-drug conjugates (ADCs) targeting TROP-2 in lung cancer 165
Infections and Immunotherapy in Lung Cancer: A Bad Relationship? 164
Exercise for counteracting post-acute COVID-19 syndrome in patients with cancer: an old but gold strategy? 161
Maintenance or consolidation therapy in small-cell lung cancer: an updated systematic review and meta-analysis 160
Physical activity guidelines in oncology: a systematic review of the current recommendations 156
Effect of exercise on functional capacity in patients with advanced cancer: A meta-analysis of randomized controlled trials 154
Impact of exercise in patients with pancreatic cancer across different treatment phases: a systematic review 152
Exploring the Association between Health-Related Physical Fitness and Quality of Life in Patients with Cancer: A Cross-Sectional Study 151
Activity of osimeRTInib in non-small-cell lung Cancer with UNcommon epidermal growth factor receptor mutations: retrospective Observational multicenter study (ARTICUNO) 149
Efficacy and safety of afatinib for non-small-cell lung cancer: state-of-the-art and future perspectives 148
Molecular predictors of EGFR-mutant NSCLC transformation into LCNEC after frontline osimertinib: digging under the surface 147
Exercise and anemia in cancer patients: could make the difference? 145
Exercise oncology: It is time to make a change 145
Prognostic impact of Interleukin-8 levels in lung cancer: A meta-analysis and a bioinformatic validation 143
Genetic and non-genetic resistance mechanisms in non-small cell lung cancer harboring (non-ALK) oncogenic fusions 143
Exploring the feasibility of a combined exercise program for patients with advanced lung or pancreatic cancer 141
Feasibility of a novel exercise program for patients with breast cancer offering different modalities and based on patient preference 139
Plasmacytoid Dendritic Cell, Slan+-Monocyte and Natural Killer Cell Counts Function as Blood Cell-Based Biomarkers for Predicting Responses to Immune Checkpoint Inhibitor Monotherapy in Non-Small Cell Lung Cancer Patients 139
Implementation outcomes of early nutritional screening and referral for patients with thoracic cancers 136
Exercise and bone health in cancer: enemy or ally? 136
Adjuvant Targeted Therapy in Solid Cancers: Pioneers and New Glories 136
Integrating nutrition, physical exercise, psychosocial support and antiemetic drugs into CINV management: The road to success 135
Body composition derangements in lung cancer patients treated with first-line pembrolizumab: A multicentre observational study 135
Effect of exercise across the head and neck cancer continuum: a systematic review of randomized controlled trials 134
Cross-sectional survey evaluating the psychological impact of the COVID-19 vaccination campaign in patients with cancer: The VACCINATE study 132
A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC 130
Combining a 9-month tailored physical exercise program with osimertinib and denosumab in a patient affected by advanced NSCLC with multiple osteolytic bone lesions: A case report 127
Tissue- and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: the IMMINENT study 125
Nurses' perspectives on physical activity promotion in cancer patients: A qualitative research 124
Body composition as a modulator of response to immunotherapy in lung cancer: time to deal with it 122
Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed 121
Exploring the role of respiratory microbiome in lung cancer: A systematic review 120
Exercise in men with prostate cancer: how to move on? 118
Exceptional Response in BRAF p.V600E-Mutant Enteric-Type Adenocarcinoma of the Lung With Cutaneous Spread: A Case Report 116
Drive the oncologists into exercise promotion in lung cancer 115
The frontier of neoadjuvant therapy in non-small cell lung cancer beyond PD-(L)1 agents 114
Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspective 113
Overcome the Fear of Exercise in Patients With Bone Metastases: A Qualitative Study on Patients' Perception 111
Study Design and Rationale for Espera Trial: A Multicentre, Randomized, Phase II Clinical Trial Evaluating the Potential Efficacy of Adding SBRT to Pembrolizumab-Pemetrexed Maintenance in Responsive or Stable Advanced Non-Squamous NSCLC After Chemo-Immunotherapy Induction 110
Prognostic and predictive implications of tumor suppressor gene alterations in non-small cell lung cancer 109
HER2 Aberrations in NSCLC: So Close Yet So Far 107
Selpercatinib in RET-fusion positive metastatic non-small cell lung cancer: achievements and gray areas 106
Identification of Targetable Liabilities in the Dynamic Metabolic Profile of EGFR-Mutant Lung Adenocarcinoma: Thinking beyond Genomics for Overcoming EGFR TKI Resistance 106
Cardiac autonomic dysfunction in patients with cancer: exploring the role of physical exercise 105
Low fT3/fT4 ratio as a proxy for muscle wasting in patients with advanced non-small cell lung cancer treated with pembrolizumab 103
SCLC Treatment in the Immuno-Oncology Era: Current Evidence and Unmet Needs 102
The Renaissance of KRAS Targeting in Advanced Non-Small-Cell Lung Cancer: New Opportunities Following Old Failures 102
Patients with NSCLC may display a low ratio of p.T790M vs. activating EGFR mutations in plasma at disease progression: implications for personalised treatment 100
What is the role of physical exercise in the era of cancer prehabilitation? A systematic review 99
Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy 99
Meta-Analysis Exploring Tyrosine Kinase Inhibitor-Induced Weight Gain in Oncogene-Addicted NSCLC 91
Effect of exercise on bone-related outcomes in patients with cancer affected by bone metastases or bone loss: a systematic review and meta-analysis 90
Willingness, preferences, barriers, and facilitators of a multimodal supportive care intervention including exercise, nutritional and psychological approach in patients with cancer: a cross-sectional study 90
Meta-analysis of the prognostic impact of TP53 co-mutations in EGFR-mutant advanced non-small-cell lung cancer treated with tyrosine kinase inhibitors 86
Epidermal growth factor receptor exon 20 insertion variants in non-small cell lung cancer patients 86
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study 84
Deep learning for predicting immunotherapeutic efficacy in advanced non-small cell lung cancer patients: a retrospective study combining progression-free survival risk and overall survival risk 82
Unlocking New Horizons in Small-Cell Lung Cancer Treatment: The Onset of Antibody–Drug Conjugates 80
Modern Challenges for Early-Phase Clinical Trial Design and Biomarker Discovery in Metastatic Non-Small-Cell Lung Cancer 79
How a physical exercise program performed by patients may impact caregiver burden in cancer: a qualitative study 77
Immune Checkpoint Inhibitor Nivolumab and Radiotherapy in Pretreated Lung Cancer Patients: Efficacy and Safety of Combination 77
Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with "Oncogene-Addicted" Advanced Lung Adenocarcinoma: A Real-World Clinical Study 66
Physical Exercise During Neoadjuvant Treatments for Non-Small Cell Lung Cancer: The Time is Coming 66
Managing lorlatinib-induced weight gain through a structured exercise intervention in an ALK+ NSCLC patient: a case report 62
Lung Cancer Screening: An Opportunity to Promote Physical Activity? 56
Immune Checkpoint Inhibitors and Radiotherapy in NSCLC Patients: Not Just a Fluke 56
EGFR and AKT1 overexpression are mutually exclusive and associated with a poor survival in resected gastric adenocarcinomas 56
From supportive care to adjunctive treatment: the evolution in time of physical exercise and nutrition in lung cancer 53
PI3K/mTORC2-RICTOR axis in early squamous non-small-cell lung cancer: genomics, molecular expression, and clinical relevance 52
Impact of Long-Term Structured Exercise on Body Composition in an NTRK Fusion-Positive NSCLC Patient Treated With Entrectinib 52
Uncovering common transcriptional features shared by mature peripheral blood PMN-MDSCs and tumor-infiltrating neutrophils in humans 51
Telehealth-delivered exercise and nutrition intervention to improve outcomes in patients with early stage non-small cell lung cancer: protocol for the multicentre STARLighT phase II (neoadjuvant) and phase III (adjuvant) trial 47
Structured Exercise During Chemotherapy for Locally Advanced or Metastatic Pancreatic Cancer: A Single-Arm, Feasibility Trial 41
Microbiome and EGFR-mutant non-small cell lung cancer: a complex interplay 30
Oligoprogression in NSCLC with Other Actionable Oncogenic Drivers Beyond EGFR and ALK: An Emerging Entity 24
Immunotherapy in limited-stage small cell lung cancer: riding the ADRIATIC wave toward precision 19
Real-world feasibility and effectiveness of a personalized exercise program during cancer treatment: results from the CHOiCE prospective study 19
Interleukin-8: a tumor-agnostic biomarker integrating cancer biology and host response across solid tumors 17
Impact of the Oncologist's Recommendation on Exercise Levels and Quality of Life in Patients With Lung Cancer: The ORE Randomized Controlled Trial 15
Interleukin-8 in health and disease 11
Correction to: How a physical exercise program performed by patients may impact caregiver burden in cancer: a qualitative study (Supportive Care in Cancer, (2025), 33, 12, (1029), 10.1007/s00520-025-10120-9) 9
A Physical Exercise Intervention, Delivered Through In-Person or Home-Based Programs, in Patients Living With Cancer and Bone Metastases: A Single-Arm, Feasibility Study 6
Totale 11.357
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.362
article - articoli 42.718
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 644
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.724
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022150 0 0 0 9 7 10 7 16 12 6 20 63
2022/2023463 22 50 40 93 26 111 1 25 49 12 25 9
2023/2024630 14 25 59 55 57 76 62 36 36 64 91 55
2024/20252.178 99 78 89 367 65 103 147 124 337 162 213 394
2025/20266.833 337 362 612 1.139 1.653 395 600 364 551 459 190 171
2026/20271.001 114 235 292 360 0 0 0 0 0 0 0 0
Totale 11.357